{"title":"贝伐单抗(阿瓦斯汀)在阿富汗治疗增生性糖尿病视网膜病变(PDR)继发黄斑病变","authors":"M. Delsoz","doi":"10.52768/2833-2725/1096","DOIUrl":null,"url":null,"abstract":"Objective: To investigate the efficacy of intravitreal anti-VEGF therapy in the treatment of maculopathy secondary to Proliferative Diabetic Retinopathy (PDR) in Afghanistan.","PeriodicalId":108891,"journal":{"name":"Open Journal of Clinical and Medical Images","volume":"15 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bevacizumab (Avastin) in treatment of maculopathy secondary to Proliferative Diabetic Retinopathy (PDR) in Afghanistan\",\"authors\":\"M. Delsoz\",\"doi\":\"10.52768/2833-2725/1096\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: To investigate the efficacy of intravitreal anti-VEGF therapy in the treatment of maculopathy secondary to Proliferative Diabetic Retinopathy (PDR) in Afghanistan.\",\"PeriodicalId\":108891,\"journal\":{\"name\":\"Open Journal of Clinical and Medical Images\",\"volume\":\"15 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-02-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Journal of Clinical and Medical Images\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52768/2833-2725/1096\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Journal of Clinical and Medical Images","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52768/2833-2725/1096","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Bevacizumab (Avastin) in treatment of maculopathy secondary to Proliferative Diabetic Retinopathy (PDR) in Afghanistan
Objective: To investigate the efficacy of intravitreal anti-VEGF therapy in the treatment of maculopathy secondary to Proliferative Diabetic Retinopathy (PDR) in Afghanistan.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
